Form 8-K - Current report:
SEC Accession No. 0001193125-24-255130
Filing Date
2024-11-12
Accepted
2024-11-12 07:15:33
Documents
59
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d911553d8k.htm   iXBRL 8-K 28211
2 EX-99.1 d911553dex991.htm EX-99.1 72880
3 EX-99.2 d911553dex992.htm EX-99.2 53060
7 GRAPHIC g911553ex99_2s10g1.jpg GRAPHIC 102196
8 GRAPHIC g911553ex99_2s11g1.jpg GRAPHIC 120804
9 GRAPHIC g911553ex99_2s12g1.jpg GRAPHIC 133018
10 GRAPHIC g911553ex99_2s13g1.jpg GRAPHIC 32305
11 GRAPHIC g911553ex99_2s14g1.jpg GRAPHIC 108746
12 GRAPHIC g911553ex99_2s15g1.jpg GRAPHIC 82502
13 GRAPHIC g911553ex99_2s16g1.jpg GRAPHIC 87331
14 GRAPHIC g911553ex99_2s17g1.jpg GRAPHIC 116725
15 GRAPHIC g911553ex99_2s18g1.jpg GRAPHIC 107282
16 GRAPHIC g911553ex99_2s19g1.jpg GRAPHIC 89184
17 GRAPHIC g911553ex99_2s1g1.jpg GRAPHIC 52362
18 GRAPHIC g911553ex99_2s20g1.jpg GRAPHIC 101400
19 GRAPHIC g911553ex99_2s21g1.jpg GRAPHIC 95102
20 GRAPHIC g911553ex99_2s22g1.jpg GRAPHIC 87559
21 GRAPHIC g911553ex99_2s23g1.jpg GRAPHIC 92731
22 GRAPHIC g911553ex99_2s24g1.jpg GRAPHIC 37086
23 GRAPHIC g911553ex99_2s25g1.jpg GRAPHIC 82965
24 GRAPHIC g911553ex99_2s26g1.jpg GRAPHIC 110272
25 GRAPHIC g911553ex99_2s27g1.jpg GRAPHIC 106407
26 GRAPHIC g911553ex99_2s28g1.jpg GRAPHIC 101943
27 GRAPHIC g911553ex99_2s29g1.jpg GRAPHIC 111640
28 GRAPHIC g911553ex99_2s2g1.jpg GRAPHIC 274519
29 GRAPHIC g911553ex99_2s30g1.jpg GRAPHIC 100763
30 GRAPHIC g911553ex99_2s31g1.jpg GRAPHIC 86350
31 GRAPHIC g911553ex99_2s32g1.jpg GRAPHIC 30381
32 GRAPHIC g911553ex99_2s33g1.jpg GRAPHIC 102755
33 GRAPHIC g911553ex99_2s34g1.jpg GRAPHIC 102264
34 GRAPHIC g911553ex99_2s35g1.jpg GRAPHIC 75295
35 GRAPHIC g911553ex99_2s36g1.jpg GRAPHIC 135244
36 GRAPHIC g911553ex99_2s37g1.jpg GRAPHIC 107401
37 GRAPHIC g911553ex99_2s38g1.jpg GRAPHIC 83019
38 GRAPHIC g911553ex99_2s39g1.jpg GRAPHIC 103129
39 GRAPHIC g911553ex99_2s3g1.jpg GRAPHIC 80036
40 GRAPHIC g911553ex99_2s40g1.jpg GRAPHIC 84864
41 GRAPHIC g911553ex99_2s41g1.jpg GRAPHIC 109879
42 GRAPHIC g911553ex99_2s42g1.jpg GRAPHIC 100230
43 GRAPHIC g911553ex99_2s4g1.jpg GRAPHIC 65663
44 GRAPHIC g911553ex99_2s5g1.jpg GRAPHIC 109839
45 GRAPHIC g911553ex99_2s6g1.jpg GRAPHIC 37002
46 GRAPHIC g911553ex99_2s7g1.jpg GRAPHIC 126887
47 GRAPHIC g911553ex99_2s8g1.jpg GRAPHIC 97003
48 GRAPHIC g911553ex99_2s9g1.jpg GRAPHIC 90756
49 GRAPHIC g911553g1112092322470.jpg GRAPHIC 2222
50 GRAPHIC g911553g87x65.jpg GRAPHIC 6690
  Complete submission text file 0001193125-24-255130.txt   5929345

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20241112.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20241112_lab.xml EX-101.LAB 17996
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20241112_pre.xml EX-101.PRE 11267
62 EXTRACTED XBRL INSTANCE DOCUMENT d911553d8k_htm.xml XML 3670
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

EIN.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 241443251
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)